{
    "2018-03-09": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Top Stock Reports for Coca-Cola, Eli Lilly & Occidental Petroleum",
                "features": {
                    "keywords": [
                        "Coca-Cola",
                        "Eli Lilly",
                        "Occidental Petroleum"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "pharmaceuticals",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "What’s AstraZeneca’s Valuation in March 2018?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "valuation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails",
                "features": {
                    "keywords": [
                        "MRK",
                        "cancer deal",
                        "DERM",
                        "acne candidate fails"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-25",
                "original_text": "Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology",
                "features": {
                    "keywords": [
                        "Maura Dickler",
                        "Lilly Oncology",
                        "Vice President",
                        "Late Phase Development"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails",
                "features": {
                    "keywords": [
                        "MRK",
                        "cancer deal",
                        "DERM",
                        "acne candidate fails"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}